sharecast

{{ storiesRelated.title }}

Hot/Cold Sectors
30 Jul
ep establecimientovodafone
Sector movers: M&A chatter lifts Vodafone, offsetting tech malaise

Cyclicals paced gains in the market place on Monday, as M&A chatter boosted stock in mobile telecommunications services vendor Vodafone.

23 Jul
Joe Garner BT Group Openreach Nationwide
Sector movers: Fixed-line telecoms wanted after government reveals broadband proposals

Fixed line telecommunications providers were at the top of the leaderboard at the start of the week after news broke that the government would help finance the roll-out of full-fibre broadband services across the UK.

13 Jul
games workshop warhammer
Sector movers: Games Workshop to cap off 'amazing' year, food producers crumble

Leisure goods and tech stocks led the risers on a positive day for London stocks, while all food producers were in the red.

11 Jul
Sector movers: Resources stocks rocked by trade worries

Commodities-related sectors were generally the worst hit in London on Wednesday after President Trump whipped out his latest trade bazooka, with only two sectors in positive territory.

10 Jul
Sector movers: Tech takes off, defensives decline again

Tech stocks were among the main risers on Tuesday, while utilities and telecoms again were the main presence on the downside.

09 Jul
Sector movers: Oil services sector in the green

Stock markets the world over were rallying amid a 'risk on' mood on Monday.

06 Jul
Sector movers: Utilities gain as US wage miss hits Treasury yields

London stocks ended up almost flat on Friday, with utiliites on the up, while non-life insurers and food producers dragged.

04 Jul
Sector movers: Commodities and industrials weigh as trade fears remain

Industrial metals & mining, industrial engineering and oil services sectors were all swathed in red on Wednesday, while telecoms stocks were generally ringing up gains.

02 Jul
pfizer mexico
Sector movers: Pharma sector slumps on Pfizer 'backlash' report

Health stocks were in the red as investors prepared for potential "pharma backlash" after Viagra was reported to have increased the price of dozens of its drugs.